Cdc7-IN-17

• UNSPSC Description:

  Cdc7-IN-17 is a potent CDC7 inhibitor with an IC50 of [1].

• Target Antigen:

  CDK

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/cdc7-in-17.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1C2=C(C=C(C3=NNC=C3)S2)N=C([C@@H](N)C(C)C)N1

• Molecular Weight:

  289.36

• References & Citations:

  [1]Hai-Jun Zhang, et al. Substituted [5,6]cyclic-4(3h)-pyrimidinones as anticancer agents. Patent WO2018217439A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2253686-94-9